Literature DB >> 8094272

Role of alpha- and beta-adrenoceptors in sympathetically mediated thermogenesis.

E E Blaak1, M A van Baak, K P Kempen, W H Saris.   

Abstract

This study was intended to investigate the role of alpha- and beta-adrenoceptor populations in the sympathetically mediated thermogenesis in healthy lean males. In the first study, the beta 1-, beta 2-, and beta 3-agonist isoprenaline was infused in increasing doses with and without simultaneous infusion of the beta 1-blocker atenolol (Iso and Iso+AT, respectively). There was an increase in whole body energy expenditure (EE) after infusing Iso+AT (P < 0.001) and an almost twofold higher increase after infusion of Iso only (P < 0.001). Stimulation of the beta 2-adrenoceptors by a specific agonist (salbutamol) resulted in a significant increase in EE (P < 0.001). The effect of stimulation of alpha 1-adrenoceptors on EE was measured by infusing increasing doses of the alpha 1-agonist phenylephrine. EE did not change, whereas blood pressure (BP) increased (P < 0.001) and heart rate decreased (P < 0.01). In addition to this study, the alpha 1-, alpha 2-, beta 1-, beta 2-, and beta 3-agonists norepinephrine and epinephrine were infused with simultaneous infusion of the beta 1- and beta 2-blocker propranolol. In both studies, there was no effect on EE, whereas BP increased (P < 0.01). In conclusion, in healthy male lean volunteers both beta 1- and beta 2-adrenoceptors are involved in the sympathetically mediated thermogenesis, whereas the alpha 1-, alpha 2-, and beta 3-adrenoceptors do not play a role.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094272     DOI: 10.1152/ajpendo.1993.264.1.E11

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Exercise metabolism and beta-blocker therapy. An update.

Authors:  A Head
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

Review 2.  Effect of exercise intensity, duration and mode on post-exercise oxygen consumption.

Authors:  Elisabet Børsheim; Roald Bahr
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Modulation of adrenergic receptors and adrenergic functions in cold adapted humans.

Authors:  Ladislav Janský; Stanislav Vybíral; Miloslava Trubacová; Jan Okrouhlík
Journal:  Eur J Appl Physiol       Date:  2007-12-04       Impact factor: 3.078

4.  Impact of circadian misalignment on energy metabolism during simulated nightshift work.

Authors:  Andrew W McHill; Edward L Melanson; Janine Higgins; Elizabeth Connick; Thomas M Moehlman; Ellen R Stothard; Kenneth P Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

5.  Neonatal overfeeding causes higher adrenal catecholamine content and basal secretion and liver dysfunction in adult rats.

Authors:  E P S Conceição; E G Moura; I H Trevenzoli; N Peixoto-Silva; C R Pinheiro; V Younes-Rapozo; E Oliveira; P C Lisboa
Journal:  Eur J Nutr       Date:  2012-09-29       Impact factor: 5.614

6.  Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.

Authors:  L Burdet; B de Muralt; Y Schutz; J W Fitting
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

7.  Chronic sympathetic attenuation and energy metabolism in autonomic failure.

Authors:  Cyndya Shibao; Maciej S Buchowski; Kong Y Chen; Chang Yu; Italo Biaggioni
Journal:  Hypertension       Date:  2012-04-02       Impact factor: 10.190

8.  Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Authors:  Kazuko Masuo
Journal:  Int J Hypertens       Date:  2010-10-21       Impact factor: 2.420

9.  ADRB3 polymorphism rs4994 (Trp64Arg) associates significantly with bodyweight elevation and dyslipidaemias in Saudis but not rs1801253 (Arg389Gly) polymorphism in ARDB1.

Authors:  Maha Daghestani; Mazin Daghestani; Mamoon Daghistani; Abdelmoneim Eldali; Zeinab K Hassan; Maha H Elamin; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

10.  Adiponectin reduces thermogenesis by inhibiting brown adipose tissue activation in mice.

Authors:  Liping Qiao; Hyung sun Yoo; Chris Bosco; Bonggi Lee; Gen-Sheng Feng; Jerome Schaack; Nai-Wen Chi; Jianhua Shao
Journal:  Diabetologia       Date:  2014-02-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.